As you develop new products that offer novel or additional patient health outcomes, DKP creates and communicates a clear understanding of the reimbursement environment that you are entering. In early development, we may even help to guide which market to enter as some pose more challenging reimbursement obstacles than others. The DKP Lifecycle Solutions™ strategic consulting team maps out the market expectations and trending drivers for change, so you can develop effective planning strategies, whether acquiring a drug or developing an internal asset, and prepare for market conditions to ensure patient access to new therapeutics and supportive care agents.

As a product nears market commercialization, the DKP team evaluates clinical trial outcomes and determines the product’s and company’s strengths and weakness and the impact that they may have on payer uptake, provider reimbursement, patient cost share, and patient access. Using qualitative research (live advisory forums or in-depth interviews) or quantitative survey approaches, we capture timely information on feedback for crafting product value propositions. DKP not only creates the big picture but takes the level of understanding down to the local implementation level: what you need to understand geographic variances, payer type nuances, and decision maker needs.

DKP Lifecycle Solutions™ offers a turn-key launch solution that has a solid track record. We understand what makes a difference to gain market uptake, whether the product is applied to complex orphan/ultra-orphan conditions, or encompasses the nuances between payer management of physician-administered and self-administered oncology agents. Our role is to provide a clear path and timing for that process, anticipating potential challenges – and opportunities – along the way. The DKP team expertise encompasses such launch roles as:

• Pricing compendia uptake
• Clinical compendia strategies
• National CMS positioning
• Local Medicare Administrative Contractor (MAC) coverage
• Medicaid coverage and access development
• Commercial payer positioning

Our success with product launch is what keeps many clients such as yourself coming back with subsequent pipeline assets.

The unknown in the market after launch is understanding what actions the payers are taking related to your product. Through the application of DKP PayerScope® market monitoring, you can track payer uptake, related to relevant endpoints such as:

• Formal published policy
• Prior authorization status and criteria
• Utilization management criteria
• Specialty pharmacy program integration
• Formulary positioning
• Comparator product parity

Whether Medicare, Medicaid, or commercial payers, DKP PayerScope® market monitoring can be the eyes and ears of your company to make sure you know where your product stands. Not forgetting other stakeholders in the market, DKP will consistently gather insights from providers, employers, and other market drivers to help paint a picture of the market as it is. During this phase, the DKP Lifecycle Solutions™ team uses all the cumulative data to help perform trending analytics and determine what might come around the next corner that you need to prepare for.